Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | GLA | P06280 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 3/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 2/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | ELANE | P08246 | 1/20 | 0.40 |
| ▸ | PRTN3 | P24158 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4435895 | 1.00 | KMT2A (0.45) | KMT2AKDM4EPOLBATMGLA | |
| SCHEMBL31412797 | 1.00 | KMT2A (0.45) | KMT2AKDM4EPOLBATMGLA | |
| SCHEMBL15428443 | 0.88 | HCAR2 (0.50) | KMT2AKDM4EPOLBALDH1A1HSD17B10 | |
| SCHEMBL15428444 | 0.88 | HCAR2 (0.50) | KMT2AKDM4EPOLBALDH1A1HSD17B10 | |
| SCHEMBL27083626 | 0.86 | KMT2A (0.52) | KMT2AKDM4EPOLBATMGLA | |
| SCHEMBL16269041 | 0.79 | ALDH1A1 (0.53) | KMT2AKDM4EPOLBATMGLA | |
| SCHEMBL16269043 | 0.79 | ALDH1A1 (0.53) | KMT2AKDM4EPOLBATMGLA | |
| SCHEMBL16269403 | 0.78 | KMT2A (0.61) | KMT2AKDM4EPOLBALDH1A1MAPT | |
| SCHEMBL16269402 | 0.78 | KMT2A (0.61) | KMT2AKDM4EPOLBALDH1A1MAPT | |
| SCHEMBL16269400 | 0.78 | KMT2A (0.61) | KMT2AKDM4EPOLBALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116568786-A | Synergistic perfuming composition | 弗门尼舍有限公司 | 2023-08-08 | — | — | CN | claimed |
| US-20230093639-A1 | PERFUME SYSTEM FOR PERFUMED CONSUMER PRODUCT | FIRMENICH SA (CH) | 2023-03-23 | — | — | US | claimed |
| WO-2006102777-A1 | SKIN LIGHTENING METHODS, COMPOSITIONS AND PRODUCTS | GIVAUDAN SA (CH) | 2006-10-05 | — | — | WO | claimed |
| EP-4301834-B9 | USE OF ENZYMES FOR IMPROVING FRAGRANCE DEPOSITION | NOVOZYMES AS (DK) | 2025-06-18 | — | — | EP | disclosed |
| EP-4301834-B1 | USE OF ENZYMES FOR IMPROVING FRAGRANCE DEPOSITION | NOVOZYMES AS (DK) | 2025-04-09 | — | — | EP | disclosed |
| EP-4446001-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2024-10-16 | — | — | EP | disclosed |
| EP-3720936-B1 | 3,7-DIMETHYLOCT-6-EN-1-YL METHYL CARBONATE AS PERFUME INGREDIENT | GIVAUDAN SA (CH) | 2024-08-14 | — | — | EP | disclosed |
| US-20240173230-A1 | FRAGRANCE COMPOSITION | GIVAUDAN SA (CH) | 2024-05-30 | — | — | US | disclosed |
| US-20240141259-A1 | USE OF ENZYMES FOR IMPROVING FRAGRANCE DEPOSITION | NOVOZYMES A/S (DK) | 2024-05-02 | — | — | US | disclosed |
| US-20240050335-A1 | A SYNERGISTIC PERFUMING COMPOSITION | FIRMENICH & CIE (CH) | 2024-02-15 | — | — | US | disclosed |
| EP-4319715-A1 | FRAGRANCE COMPOSITION | Givaudan SA (CH) | 2024-02-14 | — | — | EP | disclosed |
| WO-2017097884-A1 | SUBSTITUTED CYCLOPENTYL- AND CYCLOHEXYL-DERIVATIVES USEFUL FOR PERFUMERY | GIVAUDAN SA (CH) | 2017-06-15 | — | — | WO | disclosed |
| US-20170073614-A1 | Perfume Compositions | GIVAUDAN SA (CH) | 2017-03-16 | — | — | US | disclosed |
| WO-2017017152-A1 | 2,4,7-TRIMETHYLOCT-6-EN-1-OL AS FRAGANCE INGREDIENT | GIVAUDAN SA (CH) | 2017-02-02 | — | — | WO | disclosed |
| WO-2016097024-A1 | PERFUME COMPOSITIONS | GIVAUDAN SA (CH) | 2016-06-23 | — | — | WO | disclosed |
| EP-3004157-A1 | OLFACTORY RECEPTORS INVOLVED IN THE PERCEPTION OF SWEAT CARBOXYLIC ACIDS AND THE USE THEREOF | ChemCom S.A. (BE) | 2016-04-13 | — | — | EP | disclosed |
| WO-2014191047-A1 | OLFACTORY RECEPTORS INVOLVED IN THE PERCEPTION OF SWEAT CARBOXYLIC ACIDS AND THE USE THEREOF | CHEMCOM S.A. (BE) | 2014-12-04 | — | — | WO | disclosed |
| EP-2136772-A2 | PERFUME COMPOSITIONS | Givaudan Nederland Services B.V. (NL) | 2009-12-30 | — | — | EP | disclosed |
| WO-2008113495-A2 | PERFUME COMPOSITIONS | GIVAUDAN NEDERLAND SERVICES B.V. (NL) | 2008-09-25 | — | — | WO | disclosed |
| WO-2006102777-A1 | SKIN LIGHTENING METHODS, COMPOSITIONS AND PRODUCTS | GIVAUDAN SA (CH) | 2006-10-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230093639-A1 | PERFUME SYSTEM FOR PERFUMED CONSUMER PRODUCT | PORCN, FAAH2, FASN | KMT2A 2287/4885KDM4E 3235/4885POLB 240/4885 |
| US-20240173230-A1 | FRAGRANCE COMPOSITION | FABP2, FABP5, FAAH2 | KMT2A 1473/4885KDM4E 2086/4885POLB 766/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.